Mesoblast Limited (MESO)

Mesoblast Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	17.2	5.9	7.5	10.21	7.43
Revenue Growth (YoY)	191.39%	-21.32%	-26.54%	37.35%	-76.88%
Cost of Revenue	39.94	39.72	52.82	63.57	85.73
Gross Profit	-22.74	-33.81	-45.32	-53.36	-78.3
Selling, General & Admin	39.31	24.98	27.48	27.21	30.87
Other Operating Expenses	0.4	-0.82	-3.51	0	-0.07
Operating Expenses	39.7	24.16	23.97	27.21	30.8
Operating Income	-62.44	-57.97	-69.29	-80.57	-109.1
Interest Expense	-21.75	-20.66	-19.44	-16.91	-15.94
Interest & Investment Income	3.55	1.82	0.83	0	0.02
Currency Exchange Gain (Loss)	-0.11	-0.08	-0.16	-0.54	1.47
Other Non Operating Income (Expenses)	-6.18	-1.57	-2.88	5.51	5.23
EBT Excluding Unusual Items	-86.93	-78.45	-90.95	-92.5	-118.32
Asset Writedown	-	-	0.08	-	-
Other Unusual Items	-14.89	-9.69	8.77	0.91	18.69
Pretax Income	-101.81	-88.15	-82.1	-91.59	-99.63
Income Tax Expense	0.33	-0.19	-0.21	-0.24	-0.82
Net Income	-102.14	-87.96	-81.89	-91.35	-98.81
Net Income to Common	-102.14	-87.96	-81.89	-91.35	-98.81
Shares Outstanding (Basic)	1,208	987	778	683	605
Shares Outstanding (Diluted)	1,208	987	778	683	605
Shares Change (YoY)	22.41%	26.87%	13.89%	12.86%	14.42%
EPS (Basic)	-0.08	-0.09	-0.11	-0.13	-0.16
EPS (Diluted)	-0.08	-0.09	-0.11	-0.13	-0.16
Free Cash Flow	-50.63	-48.73	-63.53	-65.94	-102.4
Free Cash Flow Per Share	-0.04	-0.05	-0.08	-0.10	-0.17
Gross Margin	-132.22%	-	-	-	-
Operating Margin	-363.08%	-982.24%	-923.73%	-789.09%	-1467.53%
Profit Margin	-593.92%	-1490.27%	-1091.71%	-894.59%	-1329.18%
Free Cash Flow Margin	-294.42%	-825.63%	-846.99%	-645.76%	-1377.40%
EBITDA	-58.18	-56.08	-66.84	-77.91	-106.52
D&A For EBITDA	4.26	1.9	2.45	2.66	2.57
EBIT	-62.44	-57.97	-69.29	-80.57	-109.1
Revenue as Reported	17.2	5.9	7.5	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q